ConductScience.org, home

Paper41536985

SLC39A10 drives M2 macrophage polarization and gastric cancer progression through the MAPK14(p38α) pathway.

Liang Y and 6 others. iScience, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. SLC39A10 drives M2 macrophage polarization and gastric cancer progression through the MAPK14(p38α) pathway. Papers, record 41536985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41536985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SLC39A10 drives M2 macrophage polarization and gastric cancer progression through the MAPK14(p38α) pathway.
PubMed
Journal
iScience
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-17
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liang YYinhua
2Li MMengting
3Zhang CChihao
4Pan CChunpeng
5Wang SShoulian
6Xu XXin
7Yu JJiwei

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129324807VEGF may contribute to macrophage recruitment and M2 polarization in the decidua.PLoS One2018https://conductscience.org/library/papers/29324807PubMed
238339430Claudin 18.2 as a New Biomarker in Gastric Cancer-What Should We Know?Cancers (Basel)2024https://conductscience.org/library/papers/38339430PubMed
337211559Macrophages in immunoregulation and therapeutics.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37211559PubMed
436139403Targeting Gastric Cancer Stem Cells to Enhance Treatment Response.Cells2022https://conductscience.org/library/papers/36139403PubMed
529180421Metal transporter Slc39a10 regulates susceptibility to inflammatory stimuli by controlling macrophage survival.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/29180421PubMed
631845513The Interaction of Sodium and Zinc in the Priming of T Cell Subpopulations Regarding Th17 and Treg Cells.Mol Nutr Food Res2020https://conductscience.org/library/papers/31845513PubMed
738459596Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression.Mol Cancer2024https://conductscience.org/library/papers/38459596PubMed
836078080TcpC Inhibits M1 but Promotes M2 Macrophage Polarization via Regulation of the MAPK/NF-κB and Akt/STAT6 Pathways in Urinary Tract Infection.Cells2022https://conductscience.org/library/papers/36078080PubMed
935141222Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.Front Cell Dev Biol2022https://conductscience.org/library/papers/35141222PubMed
1037245017Gastric cancer treatment: recent progress and future perspectives.J Hematol Oncol2023https://conductscience.org/library/papers/37245017PubMed
1138542354Gastric Cancer in the Era of Epigenetics.Int J Mol Sci2024https://conductscience.org/library/papers/38542354PubMed
1237032648Paeonol alleviates neuropathic pain by modulating microglial M1 and M2 polarization via the RhoA/p38MAPK signaling pathway.CNS Neurosci Ther2023https://conductscience.org/library/papers/37032648PubMed
1334395329SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma.J Hepatocell Carcinoma2021https://conductscience.org/library/papers/34395329PubMed
1437548941Mesenchymal Stem Cell-Derived Exosomes Promote Recovery of The Facial Nerve Injury through Regulating Macrophage M1 and M2 Polarization by Targeting the P38 MAPK/NF-Κb Pathway.Aging Dis2024https://conductscience.org/library/papers/37548941PubMed
1528449873Progress in tumor-associated macrophage (TAM)-targeted therapeutics.Adv Drug Deliv Rev2017https://conductscience.org/library/papers/28449873PubMed
1636936929Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer.Front Immunol2023https://conductscience.org/library/papers/36936929PubMed
1730718830Macrophages as regulators of tumour immunity and immunotherapy.Nat Rev Immunol2019https://conductscience.org/library/papers/30718830PubMed
1837524874SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the CK2-mediated MAPK/ERK and PI3K/AKT pathways.Exp Mol Med2023https://conductscience.org/library/papers/37524874PubMed
1932626961SB203580 protects against inflammatory response and lung injury in a mouse model of lipopolysaccharide‑induced acute lung injury.Mol Med Rep2020https://conductscience.org/library/papers/32626961PubMed
2025074919Zinc transporter SLC39A10/ZIP10 controls humoral immunity by modulating B-cell receptor signal strength.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25074919PubMed

See all 38 referencesDownload CSV of references

Genes35

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
ARG1383PubTator's text mininghttps://conductscience.org/library/genes/383NCBI Gene
ATF21386PubTator's text mininghttps://conductscience.org/library/genes/1386NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
DAPK31613PubTator's text mininghttps://conductscience.org/library/genes/1613NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL12B3593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL133596PubTator's text mininghttps://conductscience.org/library/genes/3596NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene
ISYNA151477PubTator's text mininghttps://conductscience.org/library/genes/51477NCBI Gene
KDR3791PubTator's text mininghttps://conductscience.org/library/genes/3791NCBI Gene
MAP2K35606PubTator's text mininghttps://conductscience.org/library/genes/5606NCBI Gene
MAPK135603PubTator's text mininghttps://conductscience.org/library/genes/5603NCBI Gene
MAPK141432PubTator's text mininghttps://conductscience.org/library/genes/1432NCBI Gene
MAPKAPK29261PubTator's text mininghttps://conductscience.org/library/genes/9261NCBI Gene

See all 35 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41536985

GET https://conductscience.org/api/papers/v1/41536985/references?page=2